Journal of Clinical Medicine (Dec 2022)

Inflammaging and Blood Pressure Profiles in Late Life: The Screening for CKD among Older People across Europe (SCOPE) Study

  • Lisanne Tap,
  • Andrea Corsonello,
  • Mirko Di Rosa,
  • Paolo Fabbietti,
  • Francesc Formiga,
  • Rafael Moreno-González,
  • Johan Ärnlöv,
  • Axel C. Carlsson,
  • Harmke A. Polinder-Bos,
  • Regina E. Roller-Wirnsberger,
  • Gerhard H. Wirnsberger,
  • Tomasz Kostka,
  • Agnieszka Guligowska,
  • Rada Artzi-Medvedik,
  • Ilan Yehoshua,
  • Christian Weingart,
  • Cornel C. Sieber,
  • Pedro Gil,
  • Sara Lainez Martinez,
  • Fabrizia Lattanzio,
  • Francesco U. S. Mattace-Raso

DOI
https://doi.org/10.3390/jcm11247311
Journal volume & issue
Vol. 11, no. 24
p. 7311

Abstract

Read online

The neutrophil-to-lymphocyte ratio (NLR) is a marker for systemic inflammation. Since inflammation plays a relevant role in vascular aging, the aim of this study was to investigate whether NLR is associated with blood pressure profiles in older adults. This study was performed within the framework of the SCOPE study including 2461 outpatients aged 75 years and over. Mean blood pressure values, namely systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP) were investigated across tertiles of NLR. Change in blood pressure levels in 2 years of follow-up were compared across categories of baseline NLR. Data of 2397 individuals were used, of which 1854 individuals had hypertension. Mean values of blood pressure did not differ across categories of baseline NLR in individuals without hypertension. Individuals with hypertension with a high-range NLR had lower SBP and PP when compared to those in low-range NLR (mean difference SBP −2.94 mmHg, p = 0.032 and PP −2.55 mmHg, p = 0.030). Mean change in blood pressure in 2 years did only slightly differ in non-clinically relevant ranges, when compared across tertiles of baseline NLR. NLR as a marker of inflammaging was not associated with unfavorable blood pressure profiles in older individuals with or without hypertension.

Keywords